Literature DB >> 36239104

Pathogenesis and prognosis of primary oral squamous cell carcinoma based on microRNAs target genes: a systems biology approach.

Amir Taherkhani1, Shahab Shahmoradi Dehto2, Shokoofeh Jamshidi3, Setareh Shojaei2.   

Abstract

Oral squamous cell carcinoma (OSCC) is the most prevalent head and neck malignancy, with frequent cervical lymph-node metastasis, leading to a poor prognosis in OSCC patients. The present study aimed to identify potential markers, including microRNAs (miRNAs) and genes, significantly involved in the etiology of early-stage OSCC. Additionally, the main OSCC's dysregulated Gene Ontology annotations and significant signaling pathways were identified. The dataset GSE45238 underwent multivariate statistical analysis in order to distinguish primary OSCC tissues from healthy oral epithelium. Differentially expressed miRNAs (DEMs) with the criteria of p-value < 0.001 and |Log2 fold change| > 1.585 were identified in the two groups, and subsequently, validated targets of DEMs were identified. A protein interaction map was constructed, hub genes were identified, significant modules within the network were illustrated, and significant pathways and biological processes associated with the clusters were demonstrated. Using the GEPI2 database, the hub genes' predictive function was assessed. Compared to the healthy controls, main OSCC had a total of 23 DEMs. In patients with head and neck squamous cell carcinoma (HNSCC), upregulation of CALM1, CYCS, THBS1, MYC, GATA6, and SPRED3 was strongly associated with a poor prognosis. In HNSCC patients, overexpression of PIK3R3, GIGYF1, and BCL2L11 was substantially correlated with a good prognosis. Besides, "proteoglycans in cancer" was the most significant pathway enriched in the primary OSCC. The present study results revealed more possible mechanisms mediating primary OSCC and may be useful in the prognosis of the patients with early-stage OSCC.

Entities:  

Keywords:  biomarkers; cancer; head and neck; oral; pathogenesis; prognosis

Year:  2022        PMID: 36239104      PMCID: PMC9576470          DOI: 10.5808/gi.22038

Source DB:  PubMed          Journal:  Genomics Inform        ISSN: 1598-866X


  70 in total

1.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy.

Authors:  Katarzyna Barczyk; Michael Kreuter; Juliusz Pryjma; Evan P Booy; Subbareddy Maddika; Saeid Ghavami; Wolfgang E Berdel; Johannes Roth; Marek Los
Journal:  Int J Cancer       Date:  2005-08-20       Impact factor: 7.396

Review 3.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

4.  Role of stromal thrombospondin-1 in motility and proteolytic activity of oral squamous cell carcinoma cells.

Authors:  Yasutaka Hayashido; Masahiro Nakashima; Kazuhiko Urabe; Hideo Yoshioka; Yukio Yoshioka; Tomoaki Hamana; Hisataka Kitano; Koh-Ichi Koizumi; Tesuji Okamoto
Journal:  Int J Mol Med       Date:  2003-10       Impact factor: 4.101

5.  Cytoscape 2.8: new features for data integration and network visualization.

Authors:  Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Trey Ideker
Journal:  Bioinformatics       Date:  2010-12-12       Impact factor: 6.937

6.  An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.

Authors:  R Sulahian; F Casey; J Shen; Z R Qian; H Shin; S Ogino; B A Weir; F Vazquez; X S Liu; W C Hahn; A J Bass; V Chan; R A Shivdasani
Journal:  Oncogene       Date:  2013-12-09       Impact factor: 9.867

7.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

8.  M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma.

Authors:  Meng Xiao; Jianjun Zhang; Wanjun Chen; Wantao Chen
Journal:  J Exp Clin Cancer Res       Date:  2018-07-09

9.  MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc.

Authors:  Zuojun Wang; Jinsheng Yan; Tingqian Zou; Hui Gao
Journal:  Oncol Lett       Date:  2018-06-13       Impact factor: 2.967

10.  Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study.

Authors:  Kanan Dave; Aiman Ali; Marco Magalhaes
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.